Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Graefes Arch Clin Exp Ophthalmol. 2019 Feb 21;257(4):677–688. doi: 10.1007/s00417-019-04274-6

Figure 3:

Figure 3:

Representative optical coherence tomography colorized three-dimensional (3D) volumes of a preterm infant with zone I stage 3 retinopathy of prematurity, prior to (a) and three weeks after (b) intravitreal bevacizumab injection. The yellow arrows in a indicating extraretinal neovascular tissue is seen regressing three weeks later.